Noori N, Honarkar E, Goldfarb DS, Kalantar-Zadeh K, Taheri M, Shakhssalim N,
In placebo-controlled adjunctive epilepsy trials in adults receiving topiramate 200 to 1,000 mg/day, hot flashes (1% to 2%), drug-induced body odor (0% to 1%), skin disorder (1% to 2%), hyperhidrosis (1% or less), and erythematous rash (1% or less) were reported with equal or greater frequency than placebo
Whilst berberine may offer modest metabolic benefits through various mechanisms, it should not be viewed as a replacement for evidence-based medical treatments or lifestyle modifications that form the cornerstone of metabolic disease management
Prescription medication is available only if a licensed healthcare provider determines it is clinically appropriate after review
(Berberine)